Osmolar gap

Computes calculated serum osmolality from Na, glucose, and BUN, then subtracts from a measured osmometer reading to expose osmotically active substances not accounted for by routine chemistry — primarily ethylene glycol and its metabolites in veterinary emergency medicine.

Open calculator →

Clinical background

The osmolar gap is the difference between the directly measured serum osmolality (by freezing-point or vapor-pressure osmometry) and a calculated value derived from the three largest osmotic contributors in plasma: sodium with its paired anions, glucose, and urea. The gap exposes osmotically active substances that are not accounted for by routine chemistry. In small animal emergency medicine, the dominant clinical use is suspected ethylene glycol toxicosis; secondary uses include DKA and hyperosmolar nonketotic syndrome workup, mannitol therapy monitoring, and detection of less common alcohols (methanol, isopropanol).

Why a gap matters

A patient with serum osmolality of 320 mOsm/kg and a calculated osmolality of 295 mOsm/kg has 25 mOsm/kg of “missing” solute. In a healthy patient that gap should be under 10 mOsm/kg, attributable to small contributions from K, Ca, Mg, protein, and minor measurement variance. A gap of 25 is large, and it means something is in plasma that the calculated formula does not account for. The clinical task is figuring out what.

In veterinary practice the differential is short and dominated by one urgent possibility: ethylene glycol. Antifreeze remains the most common source, with garage and driveway exposures in dogs and cats. The molecule itself is osmotically active and contributes substantially to the gap within hours of ingestion. As ethylene glycol is metabolized by alcohol dehydrogenase to glycoaldehyde, glycolic acid, glyoxylic acid, and ultimately oxalate, the parent compound (with its osmotic activity) declines while the metabolites generate severe anion-gap metabolic acidosis and acute kidney injury. This is why a high-anion-gap metabolic acidosis with a normal or closing osmolar gap, late in the clinical course, does not rule out ethylene glycol.

Formula and units

The simplified osmolality formula in US units is:

calculated osmolality = 2 × Na + glucose/18 + BUN/2.8

where sodium is in mEq/L, glucose and BUN in mg/dL. The 2× multiplier on sodium reflects the obligate paired anions (predominantly chloride and bicarbonate) that accompany sodium in plasma. The division constants convert mass concentration to molar concentration: glucose MW 180 g/mol with the dL-to-L scaling gives a denominator of 18 to produce mmol/L; BUN converts via 2.8 because urea has two nitrogens (atomic mass 14 each) and the molar conversion includes the dL-to-L correction.

In SI units everything simplifies because glucose and urea are already reported in mmol/L:

calculated osmolality = 2 × Na + glucose + urea

When ethanol is present (either administered as antidote or measured from suspected ingestion), it must be added to the calculated value, otherwise it appears as part of the unmeasured gap and produces a false-positive signal for another osmole. Conversion: 4.6 mg/dL ethanol = 1 mmol/L, so the contribution to the formula is ethanol_mg_per_dL / 4.6.

The osmolar gap is then simply measured osmolality minus calculated osmolality. The conventional cutoffs in veterinary medicine, adapted from human literature, are:

• Less than 10 mOsm/kg: within normal limits
• 10 to 20 mOsm/kg: borderline; possible early or late ethylene glycol, mannitol therapy in progress, mild measurement variance
• Greater than 20 mOsm/kg: significant osmotic agent present; ethylene glycol toxicosis is the dominant veterinary differential

Time course and the diagnostic window

This is the single most important pitfall with the osmolar gap as a tool for ethylene glycol toxicosis: the gap is most useful in the early window after ingestion and may close as the parent compound is metabolized, even as the patient becomes sicker.

In dogs, ethylene glycol is detectable as an osmolar gap within 1 to 2 hours of ingestion, peaks around 3 to 6 hours, and declines steadily thereafter. By 12 to 18 hours the gap may be near normal even though the patient is in florid metabolic acidosis with rising creatinine and progressing oliguria. Cats metabolize ethylene glycol slightly more slowly and the window may extend a bit longer, but their lethal dose is also far lower (around 1.4 mL/kg of undiluted antifreeze versus 4.4 mL/kg for dogs), so the window during which both the diagnosis and the antidote are productive is narrower.

The clinical consequence is straightforward: an elevated osmolar gap in the right history strongly supports ethylene glycol toxicosis and prompts immediate antidote therapy (fomepizole preferred; ethanol as an alternative). A normal osmolar gap does NOT rule it out. If history is suggestive (witnessed or suspected ingestion, antifreeze containers chewed, suspected garage exposure) and the patient is presenting beyond about 6 to 8 hours, treat empirically and rely on anion gap, urine calcium oxalate crystals, and the clinical course.

Other differentials

Mannitol therapy contributes meaningfully to the osmolar gap during and shortly after the infusion. A patient receiving mannitol for cerebral edema or oliguric AKI will have an elevated gap; the timing of the last dose and the indication resolve the differential without the calculator’s help.

Methanol toxicosis behaves similarly to ethylene glycol from an osmolar perspective: the parent compound contributes to the gap and is then metabolized (to formaldehyde and formic acid) over a similar time course. It is rare in vet medicine, mostly windshield washer fluid or improperly stored fuel, but the differential is appropriate.

Isopropanol (rubbing alcohol) contributes to the gap and is metabolized to acetone, which extends the osmolar gap longer than ethylene glycol or methanol because acetone is itself osmotically active. Exposure is uncommon but documented.

Propylene glycol is the vehicle in several IV drugs (parenteral diazepam, phenobarbital, pentobarbital, and some compounded formulations). In a critically ill patient who has received multiple doses of these drugs, an elevated osmolar gap may be partly or entirely attributable to the carrier vehicle rather than a separate toxicosis. Always consider the medication history before invoking an exotic differential.

Severe alcoholic ketoacidosis and uremic toxins can contribute small amounts to the gap (typically less than 20 mOsm/kg), particularly in late presentations.

Lab-related causes are worth noting because they generate false-positive gaps. Severe hyperlipidemia and hyperproteinemia produce a pseudohyponatremia that lowers the calculated osmolality (artificially low Na in the formula) without affecting the directly measured osmolality (which is colligative), creating a gap that is purely artifactual. Modern direct-reading sodium electrodes avoid this; older indirect potentiometric methods are still in use in some labs. If a gap looks unexpectedly large in a hyperlipemic or hyperproteinemic patient, check whether the Na is from a direct or indirect method.

Use alongside the anion gap

The osmolar gap and the anion gap are complementary, not redundant. Ethylene glycol moves through three diagnostic phases that map onto these two gaps:

In the first phase (0 to 6 hours after ingestion), the parent compound dominates: osmolar gap is high, anion gap is normal, pH may be mildly altered. This is the ideal time to diagnose and treat.

In the second phase (6 to 24 hours), the parent compound is being metabolized to organic acids: osmolar gap is falling as the anion gap rises, metabolic acidosis develops, the patient becomes clinically sick. The window for antidote therapy is closing.

In the third phase (24 hours onward), the parent compound is largely cleared and the organic acid metabolites are entrenched: osmolar gap is normal or near normal, anion gap is markedly elevated, severe metabolic acidosis, oliguric to anuric AKI. The patient needs hemodialysis and aggressive supportive care; antidote alone is no longer adequate.

A clinician seeing only the anion gap might mistake a phase-three ethylene glycol patient for any other cause of high-AG metabolic acidosis. The osmolar gap, even when normal in late presentations, completes the diagnostic picture by ruling in or out a contribution from parent compound. In practice, both gaps and the clinical history together drive the decision; no single number is sufficient.

Reference range for serum osmolality

Approximately 290–310 mOsm/kg in dogs and cats (DiBartola Ch. 9). Values above 320 define hyperosmolarity; values above 350 risk irreversible CNS injury. The reference range is similar to humans and reflects the conserved physiology of plasma osmotic regulation across mammals.

Practical workflow

The osmolar gap calculation requires three routine chemistry values (Na, glucose, BUN) and one specialized measurement (serum osmolality via osmometer). Not all veterinary labs offer osmometry on stat turnaround; in those settings the test is more useful for trending and confirmation than for time-critical decisions in the early phase of suspected toxicosis. Some reference labs run osmolality on every comprehensive panel; check what your lab does and how quickly.

When suspected ethylene glycol toxicosis is on the differential, the practical approach is: send the panel including osmolality, calculate the gap when results return, but do not delay antidote therapy in the meantime. The window for fomepizole or ethanol is too narrow to wait for a confirmatory osmolar gap, and the gap may already be closing by the time results are back. Use the gap to add or remove confidence after the fact rather than to drive the initial decision.